ArticleOrphanet journal of rare diseases2022

Understanding the socioeconomic costs of dystrophic epidermolysis bullosa in Europe: a costing and health-related quality of life study.

A Angelis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.